[1]
Marques, S.A. et al. 2018. Crohn’s Disease: General characteristics and treatment with Adalimumabe biopharmaceutical. Scientific Electronic Archives. 11, 1 (fev. 2018), 69–75. DOI:https://doi.org/10.36560/1112018594.